Immunology and Microbiology
Acute Graft Rejection
9%
Allele
36%
Allotransplantation
32%
ANCA Associated Vasculitis
6%
Antibody Mediated Rejection
13%
Antigen Expression
18%
Antigen-Presenting Cell
6%
B Cell
9%
Blood Plasma
15%
Bronchiolitis
7%
CCR5
6%
CD4
6%
Complement Activation
13%
Complement Component C3d
6%
Complement Lectin Pathway
13%
Cytotoxic T Cell
12%
DNA Virus
12%
Epitope
23%
Epstein Barr Virus
64%
Gene Frequency
8%
Haplotype
32%
HLA Antibody
51%
HLA Antigen
15%
Human Leukocyte Antigen
93%
Immune Complex
28%
Immune Response
17%
Immunoassay
8%
Immunosuppression
16%
Immunosuppressive Drug
10%
Inflammation Response
6%
Kidney Transplantation
61%
Lectin Pathway
10%
Liver Transplantation
24%
Lung Transplantation
37%
Mannose Binding Lectin
7%
Monospecific Antibody
42%
Precursor
12%
Prevalence
15%
Promoter Region
12%
Secretion (Process)
6%
Single Nucleotide Polymorphism
23%
Solid
7%
Solid Organ Transplantation
14%
T Cell
33%
T Helper Cell
9%
Tacrolimus
8%
Transplant Procedure
100%
Transplant Rejection
6%
Transplantation Tolerance
9%
Tumor Cell
7%
Medicine and Dentistry
Allele
18%
Allograft
9%
Amino Terminal Sequence
6%
Antibodies
8%
Antibody Mediated Rejection
11%
Bacterial Infection
12%
Bronchiolitis Obliterans
8%
Chronic Kidney Disease
7%
Classical Hodgkin Lymphoma
31%
Cohort Analysis
18%
Complement Component C3d
12%
Complement Lectin Pathway
7%
Creatinine
7%
Cytotoxic T-Cell
12%
Cytotoxicity Assay
6%
End Stage Renal Disease
8%
Endothelial Cell
15%
Epstein Barr Virus
33%
Epstein-Barr Virus
6%
Fibrosis
6%
Gene Locus
6%
Genetic Variability
7%
Genome Wide Association Study
6%
Graft Failure
20%
Graft Survival
20%
Haplotype
9%
Hazard Ratio
12%
HLA Antibody
20%
HLA-A
6%
Human Leukocyte Antigen
22%
Immunosuppressive Treatment
9%
Infection
6%
Iron Deficiency
6%
Kidney Allograft
8%
Kidney Function
9%
Kidney Graft
68%
Kidney Transplantation
26%
Liver Transplantation
24%
Lung Transplantation
24%
Mannose Binding Lectin
7%
Neoplasm
8%
Nephropathy
6%
Pediatrics
6%
Precursor
12%
Quality of Life
30%
Systematic Review
6%
T Cell
17%
Transplantation
15%
Transplantation Tolerance
9%
Tumor Cell
8%
Keyphrases
Allele Polymorphism
6%
Antibody Assay
8%
B-matching
6%
Biobank
17%
Calciprotein Particles
6%
Chronic Kidney Disease
6%
Classical Hodgkin Lymphoma
18%
Deceased Donor Transplant
7%
Donor-recipient Matching
7%
Epstein-Barr Virus
10%
Epstein-Barr Virus DNA Load
6%
Experimental Human Endotoxemia
6%
Genetic Loci
6%
Graft Outcome
6%
Health-related Quality of Life
28%
High Risk
6%
HLA Antibodies
7%
HLA Antigens
6%
HLA Class II
7%
HLA Class II Alleles
7%
HLA-A*02
6%
HLA-B
6%
HLA-DR4
6%
Human Leukocyte Antigen
36%
Human Leukocyte Antigen Antibodies
18%
Human Leukocyte Antigen Class I
7%
Human Leukocyte Antigen Class II
12%
Human Leukocyte Antigen Haplotype
6%
Interleukin-10 Gene
6%
Iron Deficiency
6%
Kidney Transplant Recipients
43%
Kidney Transplantation
9%
Load Monitoring
6%
Lymphoma Patients
14%
Lymphoproliferative Disorders
6%
New Human Leukocyte Antigen Allele
7%
Particle Counting
6%
Phenotypic Mismatch
7%
PIRCHE
9%
Post-transplant Lymphoproliferative Disorder
6%
Pretransplant
15%
Promoter Haplotypes
6%
Renal Transplant
6%
Single Antigen Bead
7%
Solid Organ Transplantation
9%
Surrogate Marker
7%
Transplant Recipients
7%
Transplantation
12%
Type-directed
6%
Vascular Remodeling
6%
